Ibaraki, Japan

Yutaka Kohno

This inventor holds 3 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1993-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Kohno. Retrieved from https://idiyas.com/inventor/yutaka-kohno-k64gs4ht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Hamamatsu, JP (1993)
  • Osaka, JP (1997)
  • Ibaraki, JP (2003)

Company Filing History:


Years Active: 1993-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yutaka Kohno: Innovator in Pharmaceutical Solutions

Introduction

Yutaka Kohno is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing remedies for male sterility and treatments for anemia. With a total of 3 patents to his name, Kohno's work has the potential to impact many lives.

Latest Patents

Kohno's latest patents include innovative solutions such as "Remedies for Male Sterility," which focuses on efficacious preparations containing an adenosine A antagonist as the active ingredient. Another significant patent is for "Pyrazolopyridine Compounds for the Treatment of Anemia," showcasing his commitment to addressing critical health issues.

Career Highlights

Kohno is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a dedication to improving health outcomes through innovative drug development.

Collaborations

Throughout his career, Kohno has collaborated with esteemed colleagues, including Tokuaki Kajiho and Itsuo Nagatomi. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Yutaka Kohno's contributions to the pharmaceutical industry exemplify the importance of innovation in addressing health challenges. His patents and collaborative efforts reflect a commitment to improving patient care and advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…